SCHEMBL30906457

CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.52

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	8/20	0.49

▸	CALCRL	Q16602	5/20	0.47

▸	RAMP1	O60894	1/20	0.45

▸	CRHR1	P34998	1/20	0.45

▸	CRHR2	Q13324	1/20	0.45

▸	RAMP3	O60896	5/20	0.44

▸	NTSR1	P30989	1/20	0.44

▸	NPY2R	P49146	1/20	0.43

▸	NPY4R	P50391	1/20	0.43

▸	NPY5R	Q15761	1/20	0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906329	0.94	CALCR (0.49)	CALCRCALCRLRAMP1CRHR1CRHR2
SCHEMBL30906559	0.94	CALCR (0.49)	CALCRCALCRLRAMP1CRHR1CRHR2
SCHEMBL30906436	0.94	CALCR (0.49)	CALCRCALCRLCRHR1CRHR2RAMP3
SCHEMBL30906433	0.94	CALCRL (0.48)	CALCRCALCRLRAMP1CRHR1CRHR2
SCHEMBL30906410	0.93	CALCRL (0.48)	CALCRCALCRLCRHR1CRHR2RAMP3
SCHEMBL30906398	0.92	CALCR (0.49)	CALCRCALCRLRAMP3NPY2RNPY4R
SCHEMBL30906384	0.92	CALCR (0.49)	CALCRCALCRLRAMP3NPY2RNPY4R
SCHEMBL30906351	0.91	CALCR (0.52)	CALCRRAMP3NTSR1NPY2RNPY4R
SCHEMBL30906390	0.91	CALCR (0.52)	CALCRRAMP3NTSR1NPY2RNPY4R
SCHEMBL30906479	0.90	CALCR (0.50)	CALCRCRHR1CRHR2RAMP3NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed